{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:53:33Z","timestamp":1785549213994,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We examined the retinal microvascular changes and associated factors in type 2 diabetes mellitus (T2DM) before and after intensive insulin therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective observational study recruited patients with T2DM and divided them into intensive insulin therapy and oral hypoglycemic agent groups. All patients enrolled in this study had diabetes without retinopathy or non-proliferative diabetic retinopathy. Optical coherence tomography angiography (OCTA) was used in all patients before treatment and at 1, 3, and 6\u00a0months after treatment. Vessel density (VD) and thickness changes in the macular and optic disc areas were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 36 eyes in the intensive insulin therapy group and 36 in the oral hypoglycemic agent group. One month after treatment, VD in the deep capillary plexus (DCP) and peripapillary capillary VD (ppVD) were significantly decreased by intensification (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009, 0.000). At three months after treatment, decreases in VD induced by intensification were found in the superficial capillary plexus (SCP), DCP, foveal density in a 300-\u03bcm-wide region around the foveal avascular area (FD-300), and ppVD (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032, 0.000, 0.039, 0.000). Six months after treatment, decreases in VD by intensification were observed in the DCP and ppVD groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000, 0.000). Vessel density showed no significant change in the oral hypoglycemic agent group after treatment. The amount of DCP-VD reduction was correlated with macular thickening (\n                      <jats:italic>r\u2009<\/jats:italic>\n                      =\u20090.348,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.038;\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.693,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000 and\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.417,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011, respectively) after intensive insulin therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Insulin-intensive treatment caused a transient reduction in vessel density in the macular and optic disc areas. DCP-VD and ppVD were more susceptible at an earlier stage. Retinal microvasculature monitoring using OCTA is vital for patients with type 2 diabetes receiving intensive insulin therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-022-02397-9","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T17:02:28Z","timestamp":1650646948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of intensive insulin therapy on the retinal microvasculature in patients with type 2 diabetes mellitus: a prospective observational study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2397_CR1","doi-asserted-by":"publisher","first-page":"e022188","DOI":"10.1136\/bmjopen-2018-022188","volume":"9","author":"R Cheloni","year":"2019","unstructured":"Cheloni R, Gandolfi SA, Signorelli C, et al. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9:e022188.","journal-title":"BMJ Open"},{"key":"2397_CR2","doi-asserted-by":"publisher","first-page":"778283","DOI":"10.3389\/fmed.2021.778283","volume":"8","author":"B Qiu","year":"2021","unstructured":"Qiu B, Zhao L, Zhang X, et al. Associations Between Diabetic Retinal Microvasculopathy and Neuronal Degeneration Assessed by Swept-Source OCT and OCT Angiography. Front Med Lausanne. 2021;8:778283.","journal-title":"Front Med Lausanne"},{"key":"2397_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","volume":"1","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1:28\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2397_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","volume":"5","author":"S Zoungas","year":"2017","unstructured":"Zoungas S, Arima H, Gerstein HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5:431\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2397_CR5","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2337\/diacare.28.12.2819","volume":"28","author":"DJ Pettitt","year":"2005","unstructured":"Pettitt DJ, Wollitzer AO, Jovanovic L, et al. Decreasing the risk of diabetic retinopathy in a study of case management. Diabetes Care. 2005;28:2819\u201322.","journal-title":"Diabetes Care"},{"key":"2397_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/diacare.7.3.236","volume":"7","author":"E van B","year":"1984","unstructured":"van B E, Hooymans J, immerman Z, et al. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care. 1984;7:236\u201342.","journal-title":"Diabetes Care"},{"key":"2397_CR7","doi-asserted-by":"crossref","unstructured":"Group TDCaCTR. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116:874\u201386","DOI":"10.1001\/archopht.116.7.874"},{"key":"2397_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","volume":"44","author":"S Feldman-Billard","year":"2018","unstructured":"Feldman-Billard S, Larger \u00c9, Massin P. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab. 2018;44:4\u201314.","journal-title":"Diabetes Metab"},{"key":"2397_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/dom.13538","volume":"21","author":"SC Bain","year":"2019","unstructured":"Bain SC, Klufas MA, Ho A, et al. Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review. Diabetes Obes Metab. 2019;21:454\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"2397_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12886-021-01988-2","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Yu Y, Liu X, et al. Quantitative analysis of retinal vessel density and thickness changes in diabetes mellitus evaluated using optical coherence tomography angiography: a cross-sectional study. BMC Ophthalmol. 2021;21:259.","journal-title":"BMC Ophthalmol"},{"key":"2397_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajo.2016.07.015","volume":"170","author":"Z Mammo","year":"2016","unstructured":"Mammo Z, Heisler M, Balaratnasingam C, et al. Quantitative Optical Coherence Tomography Angiography of Radial Peripapillary Capillaries in Glaucoma, Glaucoma Suspect, and Normal Eyes. Am J Ophthalmol. 2016;170:41\u20139.","journal-title":"Am J Ophthalmol"},{"key":"2397_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41433-020-01233-y","volume":"35","author":"Z Sun","year":"2021","unstructured":"Sun Z, Yang D, Tang Z, et al. Optical coherence tomography angiography in diabetic retinopathy: an updated review. Eye (Lond). 2021;35:149\u201361.","journal-title":"Eye (Lond)"},{"issue":"Suppl 1","key":"2397_CR13","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"DA American","year":"2014","unstructured":"American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81-90.","journal-title":"Diabetes Care"},{"issue":"4","key":"2397_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jamaophthalmol.2016.5877","volume":"135","author":"DSW Ting","year":"2017","unstructured":"Ting DSW, Tan GSW, Agrawal R, et al. Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy. JAMA Ophthalmology. 2017;135(4):306\u201312.","journal-title":"JAMA Ophthalmology."},{"key":"2397_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677\u201382.","journal-title":"Ophthalmology"},{"key":"2397_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16\u201338.","journal-title":"J Clin Endocrinol Metab"},{"key":"2397_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12886-020-01740-2","volume":"20","author":"X Li","year":"2020","unstructured":"Li X, Xie J, Zhang L, et al. Differential distribution of manifest lesions in diabetic retinopathy by fundus fluorescein angiography and fundus photography. BMC Ophthalmol. 2020;20:471.","journal-title":"BMC Ophthalmol"},{"key":"2397_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, et al. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1\u201355.","journal-title":"Prog Retin Eye Res"},{"key":"2397_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00592-018-1115-1","volume":"55","author":"D Cao","year":"2018","unstructured":"Cao D, Yang D, Huang Z, et al. Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy. Acta Diabetol. 2018;55:469\u201377.","journal-title":"Acta Diabetol"},{"key":"2397_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1167\/iovs.16-20531","volume":"58","author":"G Dimitrova","year":"2017","unstructured":"Dimitrova G, Chihara E, Takahashi H, et al. Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017;58:190\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2397_CR21","doi-asserted-by":"crossref","unstructured":"Nesper PL, Roberts PK, Onishi AC, et al. Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2017;58:BIO307\u201315.","DOI":"10.1167\/iovs.17-21787"},{"key":"2397_CR22","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2147\/OPTH.S301317","volume":"15","author":"PY Lam","year":"2021","unstructured":"Lam PY, Chow SC, Lam WC, et al. Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control. Clin Ophthalmol. 2021;15:2767\u201385.","journal-title":"Clin Ophthalmol"},{"key":"2397_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","volume":"126","author":"Z Sun","year":"2019","unstructured":"Sun Z, Tang F, Wong R, et al. OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study. Ophthalmology. 2019;126:1675\u201384.","journal-title":"Ophthalmology"},{"key":"2397_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1167\/iovs.15-18904","volume":"57","author":"AY Kim","year":"2016","unstructured":"Kim AY, Chu Z, Shahidzadeh A, et al. Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2016;57:362\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2397_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2010.06.015","volume":"150","author":"T Horii","year":"2010","unstructured":"Horii T, Murakami T, Nishijima K, et al. Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol. 2010;150:840\u20138.","journal-title":"Am J Ophthalmol"},{"key":"2397_CR26","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1111\/aos.13404","volume":"95","author":"JM Simonett","year":"2017","unstructured":"Simonett JM, Scarinci F, Picconi F, et al. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. Acta Ophthalmol. 2017;95:e751\u20135.","journal-title":"Acta Ophthalmol"},{"key":"2397_CR27","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1167\/iovs.17-23304","volume":"59","author":"AC Onishi","year":"2018","unstructured":"Onishi AC, Nesper PL, Roberts PK, et al. Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2018;59:2167\u201376.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2397_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/IAE.0000000000002037","volume":"39","author":"S Karst","year":"2019","unstructured":"Karst S, Salas M, Hafner J, et al. Three dimensional analysis of retinal microaneurysms. Retina. 2019;39:465\u201372.","journal-title":"Retina"},{"key":"2397_CR29","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1167\/iovs.14-16270","volume":"56","author":"J Yu","year":"2015","unstructured":"Yu J, Jiang C, Wang X, et al. Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study. Invest Ophthalmol Vis Sci. 2015;56:3212\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2397_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00417-015-3143-7","volume":"254","author":"G Di","year":"2016","unstructured":"Di G, Weihong Y, Xiao Z, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2016;254:873\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2397_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2147\/OPTH.S353426","volume":"16","author":"M Attia Ali Ahmed","year":"2022","unstructured":"Attia Ali Ahmed M, ShawkatAbdelhaleem A. Evaluation of Microvascular and Visual Acuity Changes in Patients with Early Diabetic Retinopathy: Optical Coherence Tomography Angiography Study. Clin Ophthalmol. 2022;16:429\u201340.","journal-title":"Clin Ophthalmol"},{"key":"2397_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/dmrr.1093","volume":"26","author":"C Hernandez","year":"2010","unstructured":"Hernandez C, Zapata MA, Losada E, et al. Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients. Diabetes Metab Res Rev. 2010;26:386\u201392.","journal-title":"Diabetes Metab Res Rev"},{"key":"2397_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444396","volume":"56","author":"U Frydkjaer-Olsen","year":"2016","unstructured":"Frydkjaer-Olsen U, Soegaard Hansen R, Simo R, et al. Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Ophthalmic Res. 2016;56:10\u20136.","journal-title":"Ophthalmic Res"},{"key":"2397_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ceo.13390","volume":"47","author":"D Cao","year":"2019","unstructured":"Cao D, Yang D, Yu H, et al. Optic nerve head perfusion changes preceding peripapillary retinal nerve fibre layer thinning in preclinical diabetic retinopathy. Clin Exp Ophthalmol. 2019;47:219\u201325.","journal-title":"Clin Exp Ophthalmol"},{"key":"2397_CR35","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1167\/iovs.11-7481","volume":"52","author":"CY Cheung","year":"2011","unstructured":"Cheung CY, Chen D, Wong TY, et al. Determinants of quantitative optic nerve measurements using spectral domain optical coherence tomography in a population-based sample of non-glaucomatous subjects. Invest Ophthalmol Vis Sci. 2011;52:9629\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2397_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11892-012-0284-5","volume":"12","author":"C Hernandez","year":"2012","unstructured":"Hernandez C, Simo R. Neuroprotection in diabetic retinopathy. Curr Diab Rep. 2012;12:329\u201337.","journal-title":"Curr Diab Rep"},{"key":"2397_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/APO.0000000000000250","volume":"8","author":"P Raman","year":"2019","unstructured":"Raman P, Singal AK, Behl A. Effect of Insulin-Like Growth Factor-1 on Diabetic Retinopathy in Pubertal Age Patients With Type 1 Diabetes. Asia Pac J Ophthalmol (Phila). 2019;8:319\u201323.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2397_CR38","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI200317455","volume":"111","author":"T Kondo","year":"2003","unstructured":"Kondo T, Vicent D, Suzuma K, et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Investig. 2003;111:1835\u201342.","journal-title":"J Clin Investig"},{"key":"2397_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000260231","volume":"224","author":"E Chantelau","year":"2010","unstructured":"Chantelau E, Meyer-Schwickerath R, Klabe K. Downregulation of serum IGF-1 for treatment of early worsening of diabetic retinopathy: a long-term follow-up of two cases. Ophthalmologica. 2010;224:243\u20136.","journal-title":"Ophthalmologica"},{"key":"2397_CR40","doi-asserted-by":"crossref","unstructured":"Rosenstock J SS, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine HOE 901 and NPH insulin. Diabetes Care. 2001;24:631\u20136.","DOI":"10.2337\/diacare.24.4.631"},{"key":"2397_CR41","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00125-009-1415-7","volume":"52","author":"J Rosenstock","year":"2009","unstructured":"Rosenstock J, Fonseca V, McGill JB, et al. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia. 2009;52:1778\u201388.","journal-title":"Diabetologia"},{"key":"2397_CR42","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00417-011-1677-x","volume":"249","author":"H Wu","year":"2011","unstructured":"Wu H, Jiang C, Gan D, et al. Different effects of low- and high-dose insulin on ROS production and VEGF expression in bovine retinal microvascular endothelial cells in the presence of high glucose. Graefes Arch Clin Exp Ophthalmol. 2011;249:1303\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2397_CR43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00125-021-05456-w","volume":"64","author":"LJ Reid","year":"2021","unstructured":"Reid LJ, Gibb FW, Colhoun H, et al. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. Diabetologia. 2021;64:1725\u201336.","journal-title":"Diabetologia"},{"key":"2397_CR44","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","volume":"27","author":"Y Li","year":"2004","unstructured":"Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care. 2004;27:2597\u2013602.","journal-title":"Diabetes Care"},{"key":"2397_CR45","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1210\/jc.2017-01922","volume":"102","author":"EJ Barrett","year":"2017","unstructured":"Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2017;102:4343\u2013410.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02397-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T18:02:37Z","timestamp":1650650557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02397-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02397-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1283682\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in compliance with the tenets of the Declaration of Helsinki. The Ethics Committee of Xuzhou Medical University Affiliated Hospital approved the study protocol (No. XYFY2019-KL071-01). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}